Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Cooper

Showing results (51-60 of 151) with videos related to

Pageof 16
Sort By:
Cancer Research|December 18, 2004
Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cellsKanwarpal S Kahlon, Christine Brown, Laurence J N Cooper, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 15, 2015
Haploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular TherapyPiyanuch Kongtim, Dean A Lee, Laurence J N Cooper, et al.
Plos One|March 8, 2013
Chimeric antigen receptor (CAR)-specific monoclonal antibody to detect CD19-specific T cells in clinical trialsBipulendu Jena, Sourindra Maiti, Helen Huls, et al.
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
T-cell genetic modification for re-directed tumor recognitionLaurence J N Cooper, Michael Kalos, David DiGiusto, et al.
Experimental Hematology|June 26, 2007
Antigen-independent and antigen-dependent methods to numerically expand CD19-specific CD8+ T cellsTontanai Numbenjapon, Lisa M Serrano, Wen-Chung Chang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
Genome-wide mapping of PiggyBac transposon integrations in primary human T cellsDaniel L Galvan, Yozo Nakazawa, Aparna Kaja, et al.
Frontiers in Bioscience (Scholar Edition)|December 29, 2011
Chimeric antibody receptors (CARs): driving T-cell specificity to enhance anti-tumor immunityPartow Kebriaei, Susan S Kelly, Pallavi Manuri, et al.
Journal of Biopharmaceutical Statistics|October 19, 2012
Bayesian continual reassessment method for dose-finding trials infusing T cells with limited sample sizeYuan Ji, Lei Feng, Ping Liu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 10, 2014
Universal artificial antigen presenting cells to selectively propagate T cells expressing chimeric antigen receptor independent of specificityDavid Rushworth, Bipulendu Jena, Simon Olivares, et al.
Human Gene Therapy|July 10, 2004
Enhanced transgene expression in quiescent and activated human CD8+ T cellsLaurence J N Cooper, Max S Topp, Cris Pinzon, et al.
Pageof 16

Showing results (51-60 of 151) with videos related to

Sort By:
Pageof 16
Cancer Research|December 18, 2004
Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cellsKanwarpal S Kahlon, Christine Brown, Laurence J N Cooper, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 15, 2015
Haploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular TherapyPiyanuch Kongtim, Dean A Lee, Laurence J N Cooper, et al.
Plos One|March 8, 2013
Chimeric antigen receptor (CAR)-specific monoclonal antibody to detect CD19-specific T cells in clinical trialsBipulendu Jena, Sourindra Maiti, Helen Huls, et al.
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
T-cell genetic modification for re-directed tumor recognitionLaurence J N Cooper, Michael Kalos, David DiGiusto, et al.
Experimental Hematology|June 26, 2007
Antigen-independent and antigen-dependent methods to numerically expand CD19-specific CD8+ T cellsTontanai Numbenjapon, Lisa M Serrano, Wen-Chung Chang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
Genome-wide mapping of PiggyBac transposon integrations in primary human T cellsDaniel L Galvan, Yozo Nakazawa, Aparna Kaja, et al.
Frontiers in Bioscience (Scholar Edition)|December 29, 2011
Chimeric antibody receptors (CARs): driving T-cell specificity to enhance anti-tumor immunityPartow Kebriaei, Susan S Kelly, Pallavi Manuri, et al.
Journal of Biopharmaceutical Statistics|October 19, 2012
Bayesian continual reassessment method for dose-finding trials infusing T cells with limited sample sizeYuan Ji, Lei Feng, Ping Liu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 10, 2014
Universal artificial antigen presenting cells to selectively propagate T cells expressing chimeric antigen receptor independent of specificityDavid Rushworth, Bipulendu Jena, Simon Olivares, et al.
Human Gene Therapy|July 10, 2004
Enhanced transgene expression in quiescent and activated human CD8+ T cellsLaurence J N Cooper, Max S Topp, Cris Pinzon, et al.
Pageof 16